Key Developments: Affymetrix Inc (AFFX.O)

AFFX.O on Nasdaq

8.36USD
12:34pm EDT
Price Change (% chg)

$-0.01 (-0.12%)
Prev Close
$8.37
Open
$8.30
Day's High
$8.42
Day's Low
$8.23
Volume
222,444
Avg. Vol
909,918
52-wk High
$9.80
52-wk Low
$3.70

Search Stocks

Latest Key Developments (Source: Significant Developments)

Affymetrix Inc Issues Q1 2013 Revenue Guidance Below Analysts' Estimates
Tuesday, 9 Apr 2013 06:00am EDT 

Affymetrix Inc announced that it expects total revenue of approximately $78 million for the first quarter of 2013, including revenue of approximately $19 million from eBioscience. Revenues for the first quarter were below expectations, primarily due to continued headwinds in gene expression business across all regions, in particular Japan. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $83 million for the first quarter of 2013.  Full Article

Affymetrix Inc Collaborate With Aqua Gen To Achieve Density View Of Marker Patterns
Tuesday, 19 Mar 2013 06:30am EDT 

Affymetrix Inc announced in collaboration with Aqua Gen, a member of the Erich Wesjohann (EW) Group GmBH and Center for Integrative Genomics (CIGENE) at the Norwegian University of Life Sciences, to genotype more than 900,000 markers per sample from the Atlantic salmon (Salmo salar), thereby achieving the capability to implement genomic selection and improve their salmon breeding program at Aqua Gen. Aqua Gen and CIGENE partnered with Affymetrix to develop the salmon genotyping screening array which consists of 923,627 SNP (Single Nucleotide Polymorphism) markers and includes both diploid and tetraploid sequence variants. The goal of the ongoing study is to identify relevant and polymorphic high resolution markers that can be used downstream for marker trait association studies, genomic selection programs, as well as for a wide variety of applications in genetics and ecology.  Full Article

Affymetrix Inc Issues FY 2013 Revenue Guidance n Line With Analysts' Estimates-Conference Call
Thursday, 14 Feb 2013 03:00pm EST 

Affymetrix Inc announced that outlook for fiscal 2013 is to grow revenue. The Company expect to have revenue in excess of $330 million for fiscal 2013. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $332 million for fiscal 2013.  Full Article

Affymetrix Inc Comments On Q1, FY 2013 Charge Guidance
Thursday, 31 Jan 2013 04:00pm EST 

Affymetrix Inc announced that for fiscal 2013, it expects to record a total charge of approximately $7 million, the majority of which will be incurred during the first quarter of 2013 except for $1.8 million which was recognized in fiscal 2012.  Full Article

Affymetrix Inc To Slash 100 Jobs-Reuters
Tuesday, 8 Jan 2013 06:11pm EST 

Reuters reported that Affymetrix Inc will slash more than 100 jobs, or 8% of its workforce, as part of a plan to help it return to profit. Affymetrix said the restructuring is likely to result in annualized savings of about $25 million, and it will take a charge of about $7 million, majority of which will incurred in the first quarter of 2013.  Full Article

Affymetrix Inc Issues Q4, FY 2012 Revenue Guidance In Line With Analysts' Estimates
Tuesday, 8 Jan 2013 05:00pm EST 

Affymetrix Inc announced that for the fourth quarter of 2012, it expects total revenue to be approximately $84 million. For fiscal 2012, it expects total revenue of approximately $295 million. According to I/B/E/S Estimates, analysts on an average are expecting the Company to report revenue of $84 million for the fourth quarter of 2012; revenue of $296 million for fiscal 2012.  Full Article

Affymetrix Inc Issues Q3 2012 Revenue Guidance
Monday, 8 Oct 2012 06:00am EDT 

Affymetrix Inc announced that based on preliminary financial data, the Company expects total revenue of approximately $80 million for the third quarter of 2012, with revenue of approximately $18 million from the eBioscience business.  Full Article

Search Stocks